Subscribe to Newsletter

Basic & Translational Research

Subspecialties Retina

You Down with 4-AP?

It’s not enough to regrow the optic nerve: to generate functional vision, you have to restore conduction too

Business & Profession Basic & Translational Research

Gene Editing: The Next Frontier in Ophthalmology

| Irv Arons

Imagine being able to edit, delete or replace defective genes. It’s happening in research labs, and will soon head to the clinic

Subspecialties Basic & Translational Research

RGCs from the FACS machine

| Michael Schubert, Mark Hillen

For retina stem cell researchers, growing and purifying lots of RGCs from hPSCs has been hard… until now

Subspecialties Basic & Translational Research

Drugs From the Deep

| Michael Schubert

Marine mammals have tear films filled with interesting antimicrobial agents – and understanding the compounds present might one day lead to new antibiotic drugs

Subspecialties Retina

Running on Empty

| Mark Hillen

Photoreceptors – and the retina in general – are highly metabolically active. But their maxed-out mitochondria can’t give much more. And when even small metabolic imbalances arise…

Subspecialties Cornea / Ocular Surface

ATOM2: Low-dose Atropine Attenuates Myopia

| Michael Schubert

5-year ATOM2 trial data confirms that 0.01% atropine is more effective at slowing myopia progression than 0.1% and 0.5% doses

Subspecialties Cornea / Ocular Surface

Corneal Anatomy: Lightning Strikes Twice

A specialized imaging technique has revealed two previously unknown structures of the cornea

Subspecialties Cornea / Ocular Surface

Dodging the Downsides of Corneal Epithelium Debridement

| Michael Schubert

A new matrix therapy agent may promote corneal healing after epi-off CXL, improving patient comfort and recovery times

Subspecialties Cornea / Ocular Surface

Benchmarking Endophthalmitis

| Mark Hillen

What does analysis of the last five years of literature on endophthalmitis tell us about the priorities of the field, and the contributors to it?

Subspecialties Retina

What’s Old is New (II)

| Michael Schubert

Placental growth factor inhibitors might show efficacy in treating dry AMD as well as wet. Might aflibercept be repurposed?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.